EUDA Net Working Capital from 2010 to 2024

EUDA Stock   4.43  0.11  2.55%   
EUDA Health's Net Working Capital is decreasing over the years with slightly volatile fluctuation. Overall, Net Working Capital is projected to go to about -7.6 M this year. From 2010 to 2024 EUDA Health Net Working Capital quarterly data regression line had arithmetic mean of (2,847,614) and significance of  0. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
-8 M
Current Value
-7.6 M
Quarterly Volatility
2.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 183.4 K or Interest Expense of 22.1 K, as well as many indicators such as Price To Sales Ratio of 11.84, Dividend Yield of 0.0 or Days Sales Outstanding of 22.38. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
  
Check out the analysis of EUDA Health Correlation against competitors.

Latest EUDA Health's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of EUDA Health Holdings over the last few years. It is EUDA Health's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

EUDA Net Working Capital Regression Statistics

Arithmetic Mean(2,847,614)
Coefficient Of Variation(73.96)
Mean Deviation1,500,745
Median(1,824,378)
Standard Deviation2,106,108
Sample Variance4.4T
Range6.2M
R-Value(0.71)
Mean Square Error2.4T
R-Squared0.50
Significance0
Slope(333,260)
Total Sum of Squares62.1T

EUDA Net Working Capital History

2024-7.6 M
2023-8 M
2022-4.1 M
2021-3 M

About EUDA Health Financial Statements

EUDA Health stakeholders use historical fundamental indicators, such as EUDA Health's Net Working Capital, to determine how well the company is positioned to perform in the future. Although EUDA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in EUDA Health's assets and liabilities are reflected in the revenues and expenses on EUDA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EUDA Health Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital-8 M-7.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:
Check out the analysis of EUDA Health Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.144
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.86)
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.